ADARx Pharmaceuticals (ADRX) Stock News
$ADRX · NASDAQ · 3 stories in 30 daysBORSA has published 3 stories on ADARx Pharmaceuticals (ADRX) in the past 30 days. BORSA’s news read on ADRX is bullish at 69/100, based on 3 company events over the past 7 days.
The wire on $ADRX
newest first · updated · direct subject stories onlyUBS initiates coverage on ADARx Pharmaceuticals with Buy rating and $35 price target
UBS initiated coverage on ADARx Pharmaceuticals (ADRX) with a Buy rating.
bullish 70 · impact 40Morgan Stanley initiates Overweight rating and $32 price target for ADARx Pharmaceuticals
Morgan Stanley initiated coverage on ADARx Pharmaceuticals (ADRX) with an Overweight rating.
bullish 70 · impact 60